Cargando…

Serum biomarkers of papillary thyroid cancer

OBJECTIVE: To identify serum biomarkers of papillary thyroid cancer. METHODS: Prospective analysis was performed of banked tumor and serum specimens from 99 patients with thyroid masses. Enzyme-linked immunosorbent assay (ELISA) was employed to measure levels of five serum proteins previously demons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makki, Fawaz M, Taylor, S Mark, Shahnavaz, Ali, Leslie, Andrew, Gallant, Jeffrey, Douglas, Susan, Teh, Evelyn, Trites, Jonathan, Bullock, Martin, Inglis, Karen, Pinto, Devanand M, Hart, Robert D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651213/ https://www.ncbi.nlm.nih.gov/pubmed/23663694 http://dx.doi.org/10.1186/1916-0216-42-16

Ejemplares similares

Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses
por: Graham, M. Elise R., et al.
Publicado: (2015)

Differential expression of transforming growth factor-beta in benign vs. papillary thyroid cancer nodules; a potential diagnostic tool?
por: Brace, Matthew D, et al.
Publicado: (2014)

Prognostic factors for metastatic cutaneous squamous cell carcinoma of the parotid
por: Makki, Fawaz M, et al.
Publicado: (2013)

Papillary thyroid cancer recurrence 43 Years following Total Thyroidectomy and radioactive iodine ablation: a case report
por: Amoako-Tuffour, Yaw, et al.
Publicado: (2017)

Tumor-to-tumor metastases: papillary thyroid carcinoma into a clear cell renal cell carcinoma
por: Song, Jin Soo Andy, et al.
Publicado: (2017)

CO(2) laser versus cold steel margin analysis following endoscopic excision of glottic cancer
por: Makki, Fawaz M, et al.
Publicado: (2014)

Rates of thyroid malignancy by FNA diagnostic category
por: Williams, Blair A, et al.
Publicado: (2013)

A targeted isotope dilution mass spectrometry assay for osteopontin quantification in plasma of metastatic breast cancer patients
por: Leslie, Andrew, et al.
Publicado: (2023)

Comparative performance of different methods for circulating tumor cell enrichment in metastatic breast cancer patients
por: Drucker, Arik, et al.
Publicado: (2020)

The role of repeat fine needle aspiration in managing indeterminate thyroid nodules
por: Allen, Laura, et al.
Publicado: (2019)

Hashimoto’s Thyroiditis and the Risk of Papillary Thyroid Cancer in Children
por: Gallant, Jean-Nicolas, et al.
Publicado: (2023)

Serum ghrelin levels in papillary thyroid carcinoma
por: Ucan, Bekir, et al.
Publicado: (2017)

Expectantly waiting: a survey of thyroid surgery wait times among Canadian Otolaryngologists
por: Brake, Maria, et al.
Publicado: (2013)

The Incidental Thyroid Lesion in Parathyroid Disease Management
por: Alamoudi, Uthman, et al.
Publicado: (2017)

Preoperative Thyrotropin Serum Concentrations Gradually Increase from Benign Thyroid Nodules to Papillary Thyroid Microcarcinomas Then to Papillary Thyroid Cancers of Larger Size
por: Zafon, Carles, et al.
Publicado: (2012)

Transoral laser microsurgery for the treatment of oropharyngeal cancer: the Dalhousie University experience
por: Melong, J.C., et al.
Publicado: (2015)

Detection and Identification of Serum Peptides Biomarker in Papillary Thyroid Cancer
por: Lu, Zhao-lian, et al.
Publicado: (2018)

Association of Serum Progranulin Levels with Progression of Papillary Thyroid Cancer
por: Kim, Won Gu
Publicado: (2020)

Predictive Significance of Serum MMP-9 in Papillary Thyroid Carcinoma
por: Xu, Dahai, et al.
Publicado: (2019)

Relationship between serum NDRG3 and papillary thyroid carcinoma
por: Wang, Jiahao, et al.
Publicado: (2022)

Serum Adiponectin and Progranulin Level in Patients with Benign Thyroid Nodule or Papillary Thyroid Cancer
por: Kwon, Hyemi, et al.
Publicado: (2020)

Surgical management of primary hyperparathyroidism in Canada
por: Williams, Blair A, et al.
Publicado: (2014)

Combined prognostic value of preoperative serum thyrotrophin and thyroid hormone concentration in papillary thyroid cancer
por: Liu, Yushu, et al.
Publicado: (2022)

TFAP2B, AP-1 and JAZF1 Expression in Tissues of Papillary Thyroid Carcinoma Patients; Clinical, Pathological and Prognostic Values
por: Abuderman, Abdulwahab A, et al.
Publicado: (2020)

Papillary Thyroid Microcarcinomas Are Different from Latent Papillary Thyroid Carcinomas at Autopsy
por: Lee, Yong Sang, et al.
Publicado: (2014)

Patient and tumor factors contributing to distant metastasis in well-differentiated thyroid cancer: a retrospective cohort study
por: Khan, Usman, et al.
Publicado: (2020)

Increased Pleiotrophin Concentrations in Papillary Thyroid Cancer
por: Jee, Youn Hee, et al.
Publicado: (2016)

MON-495 Influence of Lymphocytic Thyroiditis at Histology and Serum Thyroglobulin Autoantibodies on the Course of Papillary Thyroid Carcinoma
por: Viola, Nicola, et al.
Publicado: (2020)

Patients with papillary thyroid carcinoma associated with high stimulated serum calcitonin levels
por: Unluhizarci, Kursad, et al.
Publicado: (2017)

Serum MMP-2 as a potential predictive marker for papillary thyroid carcinoma
por: Shi, Yunpeng, et al.
Publicado: (2018)

Serum miR-22 may be a biomarker for papillary thyroid cancer
por: Wang, Deping, et al.
Publicado: (2019)

Is eNAMPT/visfatin a potential serum marker of papillary thyroid cancer?
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2022)

Papillary Thyroid Carcinoma in Paediatric Age
por: Garzi, A., et al.
Publicado: (2020)

Coexistence of papillary thyroid cancer with Hashimoto thyroiditis
por: Konturek, Aleksander, et al.
Publicado: (2012)

Thyroid papillary carcinoma associated to Hashimoto's thyroiditis
por: Campos, Luiz Alexandre Albuquerque Freixo, et al.
Publicado: (2015)

Chronic Sclerosing Osteomyelitis of the Mandible Treated with Hemimandibulectomy and Fibular Free Flap Reconstruction
por: Singh, Shubhi, et al.
Publicado: (2016)

Simultaneous medullary-papillary thyroid carcinoma
por: Al-Mashat, Faisal M. H.
Publicado: (2004)

Genetic Alterations in Papillary Thyroid Carcinoma With Hashimoto(’)s Thyroiditis： ANK3, an Indolent Maintainer of Papillary Thyroid Carcinoma
por: Zeng, Chao, et al.
Publicado: (2022)

Serum osteopontin can improve papillary thyroid cancer risk assessment of Bethesda III thyroid nodules: a preliminary study
por: Kars, T U, et al.
Publicado: (2021)

Struma Ovarii with Papillary Thyroid Carcinoma
por: Alvarez, Daniel M., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_60qtu1md27ofbopcqp84f6q87b